Cell-based agents and drugs for advanced therapies

The focus at MDTB Cells is on the deve­lo­p­ment of cell-based immu­no­mo­du­la­tory agents and drugs. The joint goal of the phar­maceu­ti­cal com­pa­nies is to deve­lop new rege­ne­ra­tive the­ra­pies for severe inflamm­a­tion-asso­cia­ted dise­a­ses and to apply them, in par­ti­cu­lar, in large pati­ent populations.